Insights

Type Clear all

Select all that apply

Topic Clear all

Select all that apply

icons/content-types/article article

As pandemic conditions persist, the pharma industry continues to respond as rapidly as possible to bring more vaccine options to the global population. But developing one or more effective vaccines was just the first hurdle to clear. The drug industr...

icons/content-types/video webinar

Watch this webinar to learn why indexing is a useful tool to glean additional information from X-ray powder diffraction data. The expert speaker will discuss the applications of indexing, including demonstrating pure crystalline phase identification...

040E93C7-D189-4233-A102-58C0580BE529 publications patents

The following research articles appeared in peer-reviewed scientific journals that described innovations conceived by Curia scientists. In most of these cases, these manuscripts were written by Curia lead authors to communicate independent research...

icons/content-types/video webinar

Presented by Pete Michels, Ph.D., Head of Global Fermentation, Curia Jose Luis Barredo, Ph.D., Director, Engineering Services, Curia Listen in as our experts discuss: A brief history of biocatalysis with a look at its current and futur...

icons/content-types/video webinar

Presented by Mark Wolf, Ph.D., Section Head, Medicinal Chemistry - Curia Doug Kitchen, Ph.D., Section Head, CADD, Medicinal Chemistry - Curia Listen in as our experts discuss: The importance of a strong hit-to-lead program in drug d...

icons/content-types/video webinar

Presented by Brian Haney, Ph.D., Director of Technical Operations, Curia Iain MacGilp, Ph.D., Director, GMP Production, Curia Listen in as our experts discuss: The basics of handling HPAPI's safely in GMP production settings The trad...

icons/content-types/white paper white paper

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...

icons/content-types/video webinar

Presenters: Ankit Agrawal, Senior Director, Commercial Strategy, Curia Anish Parikh, Vice President, Drug Product Sales & Marketing, Curia Listen in as our experts discuss: The shortage of sterile manufacturing capacity within CDMOs given...

icons/content-types/video webinar

Presenters: Peter Talbiersky, Ph.D., Manager of Fine Chemicals Sales, Curia Listen in as our experts discuss: The importance of a green and versatile condensation reagent Safe alternative for commonly used condensation reagents like dicyclohe...

icons/content-types/video webinar

Presenters: Iain MacGilp, Ph.D., Director, GMP Production, Curia Amber McFarlane, Head of Formulation Development, Curia Listen in as our experts discuss: The importance of an integrated formulation development and clinical supply function th...

icons/content-types/article article

Though synthetic biology may be regarded as a new or emerging field of science, the concept of applying biological systems to improve chemical synthesis goes back hundreds — arguably, thousands — of years. From the earliest fermentation processes...

icons/content-types/article article

As part of our deep commitment to diversity and inclusion in the workplace, Curia is very proud to be participating in the two-year Mansfield Rule: Legal Department Edition (MRLD) initiative.